Myriad Genetics (MYGN) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Myriad Genetics (MYGN) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 4.45% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 10.39% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 3.62% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 38.87% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 21.03% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -0.26% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -11.30% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 2.11% |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn | 5.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.01% |
| Dec 31, 2025 | 10.98% |
| Sep 30, 2025 | 18.18% |
| Jun 30, 2025 | 28.87% |
| Mar 31, 2025 | 35.62% |
| Dec 31, 2024 | 39.23% |
| Sep 30, 2024 | 38.54% |
| Jun 30, 2024 | 39.11% |
| Mar 31, 2024 | 37.99% |
| Dec 31, 2023 | 42.99% |
| Sep 30, 2023 | 48.71% |
| Jun 30, 2023 | 44.66% |
| Mar 31, 2023 | 37.43% |
| Dec 31, 2022 | 31.71% |
| Sep 30, 2022 | 7.06% |
| Jun 30, 2022 | -2.69% |
| Mar 31, 2022 | -8.01% |
| Dec 31, 2021 | -9.71% |
| Sep 30, 2021 | -9.78% |
| Jun 30, 2021 | 0.00% |